All posts tagged "DCGI"
-
110NEWSOrchid Pharma gets DCGI nod to market antibiotic drug combination
The Drug Controller General of India (DCGI) has granted permission to manufacture and market the finished dosage form of Cefepime and Enmetazobactam...
-
166HEALTHAntacid Digene Gel recalled by Abbott, DCGI issues alert against household medication; know why
Drug Controller General of India (DCGI) Rajeev Singh Raghuvanshi has issued an advisory to discontinue the use of antacid Digene Gel manufactured...
-
176MUST KNOWGroundbreaking Business Idea: Invest Rs 2 Lakh, Earn Rs 75K To Rs 1 Lakh Returns
Manufacturing sanitary napkins is a lucrative industry with high demand. It is a hygiene item that many ladies use all throughout the...
-
379NEWSLicenses of 18 pharma companies cancelled
Licenses of 18 pharma companies have been cancelled for manufacturing spurious medicines following an inspection by the Drugs Controller General of India...
-
323NEWSCentre Likely To Close E-Pharmacies Over Data Misuse: Report
New Delhi: The Modi government is mulling to shut E-pharmacies over misuse of data, according to a report. New Delhi: The Modi government...
-
474NEWS
Calcium, Vitamin D Pills, Painkillers, Anti-Allergens: DCGI Issues Alerts on Fake Drugs in Supply Chain
The alert included anti-allergic Montair, cardio drug Atorva, statin drug Roseday, painkiller Zerodol, loose calcium tablets and vitamin D tablets manufactured by...
-
399NEWSBharat Biotech’s Intranasal Covid-19 Booster Gets DCGI Approval for Emergency Use Authorisation
The booster dose of Bharat Biotech’s Covid-19 nasal vaccine iNCOVACC on Friday received emergency use authorisation (EUA) from the Drugs Controller General...
-
348NEWSNeedle-Free, Hassle-Free: Why India’s First Nasal Vaccine Against Covid Could be a Game-changer
Bharat Biotech’s first-of-its-kind needle-free intranasal vaccine for Covid-19 received emergency use authorization from the Drugs Controller General of India (DCGI) on Tuesday, boosting the...
-
768HEALTHDCGI approves AstraZeneca’s Lynparza as monotherapy for patients with high-risk early breast cancer
According to the company’s press statement, the approval was based on results from the OlympiA Phase III trial, which suggested that Olaparib...
-
533NEWSDespite DCGI Nod, Here’s Why Biological E’s Corbevax is Not Yet Available for Booster Shots
“How do we justify clearing a vaccine made on strains when the strain does not prevail anymore,” asked Dr J P Mulliyal,...
